4.2 Article

The E-Coach technology-assisted care transition system: a pragmatic randomized trial

期刊

TRANSLATIONAL BEHAVIORAL MEDICINE
卷 6, 期 3, 页码 428-437

出版社

OXFORD UNIV PRESS
DOI: 10.1007/s13142-016-0422-8

关键词

Care transitions; Telehealth; Self-management

资金

  1. Agency for Healthcare Research and Quality of Care of Complex Patients [R18-HS017786-02]

向作者/读者索取更多资源

Care transitions from the hospital to home remain a vulnerable time for many patients, especially for those with heart failure (CHF) and chronic obstructive pulmonary disease (COPD). Despite regular use in chronic disease management, it remains unclear how technology can best support patients during their transition from the hospital. We sought to evaluate the impact of a technology-supported care transition support program on hospitalizations, days out of the community and mortality. Using a pragmatic randomized trial, we enrolled patients (511 enrolled, 478 analyzed) hospitalized with CHF/COPD to E-Coach, an intervention with condition specific customization and in-hospital and post discharge support by a care transition nurse (CTN), interactive voice response post-discharge calls, and CTN follow-up versus usual post-discharge care (UC). The primary outcome was 30-day rehospitalization. Secondary outcomes included (1) rehospitalization and death and (2) days in the hospital and out of the community. E Coach and UC groups were similar at baseline except for gender imbalance (p= 0.02). After adjustment for gender, our primary outcome, 30-day rehospitalization rates did not differ between the E-Coach and UC groups (15.0 vs. 16.3 %, adjusted hazard ratio [95 % confidence interval]: 0.94 [0.60, 1.49]). However, in the COPD subgroup, E Coach was associated with significantly fewer days in the hospital (0.5 vs. 1.6, p= 0.03). E-Coach, an IVRaugmented care transition intervention did not reduce rehospitalization. The positive impact on our secondary outcome (days in hospital) among COPD patients, but not in CHF, may suggest that E-Coach may be more beneficial among patients with COPD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据